Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

for
Esophageal Cancer, Gastrointestinal Cancers,
Location: Dallas TX
Sponsor: John Waters

Sex: All

Age: 18+

Code: NCT07039526

Phase 2, Recruiting

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

for
Tumours, Gynecological
Location: Toronto, Montreal, Rochester NY, Durham NC, Columbus OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06796907

Phase 1, Phase 2, Recruiting

Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy

for
Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07354100

Phase 1, Phase 2, Recruiting

Evaluation of a Mobile App Program for Coping With Cancer

for
Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06923501

Recruiting

Human Observatory Study

for
Aging, Mortality, All-cause Mortality, Life Expectancy,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07646782

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

for
Metastatic Cancer, Neoplasm, Prostate, Castrate-sensitive,
Location: The Bronx NY, New York NY, Wappingers Falls NY,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: Male

Age: 18+

Code: NCT05422911

Phase 2, Recruiting

High-Resolution PET-CT Imaging for Surgical Margin Visualization

for
Cancer, Solid Malignant Tumors, SCC - Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06915454

Recruiting

BTM-3566 in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Houston TX, San Antonio TX
Sponsor: Bantam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07266285

Phase 1, Recruiting

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

for
Hematopoietic Stem Cell Transplantation, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05681026

Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase 1, Recruiting

Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

for
Cancer
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07290491

Phase 3, Recruiting

Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

for
Cancer, Parent, Fear of Cancer Recurrence, CBT,
Location: Ottawa
Sponsor: University of Ottawa

Sex: All

Age: 18+

Code: NCT06872840

Recruiting

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

for
Cancer, Fatigue, Brain Tumor Adult
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 39

Code: NCT07186556

Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase 1, Recruiting

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04984551

Phase 2, Recruiting

A Study of DS5361b in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Sarasota FL, Irving TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07182591

Phase 1, Recruiting

Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Irvine CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07184294

Recruiting

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

for
Advanced Cancer, Pancreatic Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07636382

Recruiting

FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers

for
Cancer Support, Oncology Patients, Caregivers
Location: Rochester NY, Detroit MI
Sponsor: Charles Kamen

Sex: All

Age: 18 - 70+

Code: NCT06800053

Recruiting

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for
Advanced Malignancies, Advanced Cancer
Location: North Haven CT, New Haven CT, Deerfield Beach FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07426757

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial